Acumen Pharmaceuticals Inc

NAS:ABOS (USA)  
$ 3.64 +0.08 (+2.25%) 11:08 PM EST
At Loss
P/B:
0.75
Market Cap:
$ 210.79M
Enterprise V:
$ -9.27M
Volume:
366.51K
Avg Vol (2M):
395.67K
Volume:
366.51K
At Loss
Avg Vol (2M):
395.67K

Business Description

Acumen Pharmaceuticals Inc
NAICS : 325412 SIC : 2834
ISIN : US00509G2093
Description
Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believe to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody which selectively targets amyloid-beta oligomers.
Name Current Vs Industry Vs History
Cash-To-Debt 107717
Equity-to-Asset 0.98
Interest Coverage No Debt
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year EBITDA Growth Rate -59.8
3-Year EPS without NRI Growth Rate -59.1
3-Year FCF Growth Rate -54

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 83.84
9-Day RSI 69.32
14-Day RSI 61.33
6-1 Month Momentum % -48.57
12-1 Month Momentum % -38.17

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 35.85
Quick Ratio 35.85
Cash Ratio 35.33

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -12.7
Shareholder Yield % 0.06

Financials (Next Earnings Date:2024-03-27 Est.)

ABOS's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:ABOS

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Acumen Pharmaceuticals Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) -1.12
Beta 0
Volatility % 122.01
14-Day RSI 61.33
14-Day ATR ($) 0.206504
20-Day SMA ($) 3.24
12-1 Month Momentum % -38.17
52-Week Range ($) 1.8101 - 11.3099
Shares Outstanding (Mil) 57.91

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Acumen Pharmaceuticals Inc Filings

Filing Date Document Date Form
No Filing Data

Acumen Pharmaceuticals Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Acumen Pharmaceuticals Inc Frequently Asked Questions

What is Acumen Pharmaceuticals Inc(ABOS)'s stock price today?
The current price of ABOS is $3.64. The 52 week high of ABOS is $11.31 and 52 week low is $1.81.
When is next earnings date of Acumen Pharmaceuticals Inc(ABOS)?
The next earnings date of Acumen Pharmaceuticals Inc(ABOS) is 2024-03-27 Est..
Does Acumen Pharmaceuticals Inc(ABOS) pay dividends? If so, how much?
Acumen Pharmaceuticals Inc(ABOS) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1